S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients wit
- This topic has 0 replies, 1 voice, and was last updated 9 years, 9 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma.
http://discover.luc.edu/works/19168
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.